Drug profile · INN
samarium sm-153 lexidronam pentasodium
QUADRAMET
samarium sm-153 lexidronam pentasodium (QUADRAMET) is a unknown. Route of administration: injection. Current US regulatory status: approved.
Drug details — samarium sm-153 lexidronam pentasodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
samarium sm-153 lexidronam pentasodium (QUADRAMET) is a unknown. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is samarium sm-153 lexidronam pentasodium?
samarium sm-153 lexidronam pentasodium (QUADRAMET) is a unknown. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for samarium sm-153 lexidronam pentasodium?
QUADRAMET is a marketed brand name for samarium sm-153 lexidronam pentasodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of samarium sm-153 lexidronam pentasodium?
samarium sm-153 lexidronam pentasodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.